Denali Therapeutics Inc. (DNLI) gained 7.4% or 1.29 to $18.79. It is about 643679 shares traded, which is 180.87% compare to the average total volume 355876. The market cap of DNLI is $1.78 billion. The year to date change is 15.84%. The 52 week price range is from $12.32 to $25.79. Price of DNLI have changed 0.81% during last week. It have changed 2.88% over last month, 16.21% over last 3 months, -6.47% over last 6 months and -18.46% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for DNLI is 17.99. It is -4.26% below current price. The 200-day Moving Averages for DNLI is 18.37. It is -2.24% below current price. The 52-week High is 25.79. It is 37.25% from the current price. The 52-week Low is 12.32. It is -34.43% from current price.
There are some statistics of DNLI. It is has market cap $1.78 billion. The share outstanding is 94.96 million. The average volume is 355876. The percent of top 15 Institution holding is 30.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of DNLI is -41.90%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of DNLI is -36.32%.